Literature DB >> 26057873

ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB.

Ji-Juan Gao1, Yan-Wei Hu1, Yan-Chao Wang1, Yan-Hua Sha1, Xin Ma2, Shu-Fen Li1, Jia-Yi Zhao1, Jing-Bo Lu3, Chuan Huang1, Jing-Jing Zhao1, Lei Zheng1, Qian Wang1.   

Abstract

To explore the anti-inflammatory effect of apolipoprotein M (apoM) on regulation of tumor necrosis factor-α (TNF-α)-induced expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and further investigate the molecular mechanism of apoM in this process. We found that TNF-α could decrease expression of apoM and inhibitor of NF-κB-α (IκBα) in HepG2 cells. Overexpression of apoM caused a significant decrease of ICAM-1 and VCAM-1 expression, while it caused a significant increase of IκBα expression in HepG2 cells. Furthermore, the treatment with TNF-α could increase ICAM-1 and VCAM-1 expression, decrease IκBα protein expression, and increase nuclear factor-κB (NF-κB) activity, and these effects were markedly enhanced by small interfering RNA (siRNA)-mediated silencing of apoM in HepG2 cells. Our findings demonstrated that apoM suppressed TNF-α-induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26057873      PMCID: PMC4522953          DOI: 10.1089/dna.2015.2892

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  44 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".

Authors:  Bruno Seriolo; Sabrina Paoliono; Carmela Ferrone; Maurizio Cutolo
Journal:  Joint Bone Spine       Date:  2008-12-11       Impact factor: 4.929

3.  Identification of NF-kappaB1 and NF-kappaBIAlpha polymorphisms using PCR-RFLP assay in a Turkish population.

Authors:  Serap Senol Tuncay; Pinar Okyay; Fevzi Bardakci
Journal:  Biochem Genet       Date:  2009-11-26       Impact factor: 1.890

Review 4.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

5.  Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.

Authors:  Xian-sheng Huang; Shui-ping Zhao; Min Hu; Yang-ping Luo
Journal:  Med Hypotheses       Date:  2007-01-10       Impact factor: 1.538

Review 6.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 7.  Apolipoprotein M in lipid metabolism and cardiometabolic diseases.

Authors:  Anna Borup; Pernille M Christensen; Lars B Nielsen; Christina Christoffersen
Journal:  Curr Opin Lipidol       Date:  2015-02       Impact factor: 4.776

8.  Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase.

Authors:  Liping Zhang; Jizhong Cheng; Yewei Ma; Walter Thomas; Jiqiang Zhang; Jie Du
Journal:  Circ Res       Date:  2005-10-13       Impact factor: 17.367

9.  An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma.

Authors:  Olof Axler; Josefin Ahnström; Björn Dahlbäck
Journal:  J Lipid Res       Date:  2007-05-25       Impact factor: 5.922

10.  Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation.

Authors:  C C Chen; C L Rosenbloom; D C Anderson; A M Manning
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

View more
  4 in total

1.  The Inflammatory Potential of Dietary Manganese in a Cohort of Elderly Men.

Authors:  Jacob K Kresovich; Catherine M Bulka; Brian T Joyce; Pantel S Vokonas; Joel Schwartz; Andrea A Baccarelli; Elizabeth A Hibler; Lifang Hou
Journal:  Biol Trace Elem Res       Date:  2017-08-18       Impact factor: 3.738

2.  Evaluation of the anti-gout effect of Sonchus Arvensis on monosodium urate crystal-induced gout arthritis via anti-inflammatory action - an in vivo study.

Authors:  Nita Parisa; Rachmat Hidayat; Ziske Maritska; Bintang Arroyantri Prananjaya
Journal:  Med Pharm Rep       Date:  2021-07-29

3.  Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway.

Authors:  Yang Wang; Xiangda Meng; Hua Yan
Journal:  Mol Med Rep       Date:  2017-01-25       Impact factor: 2.952

4.  Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide‑induced acute inflammatory apoM‑/‑ mice.

Authors:  Yuanping Shi; Hongyao Liu; Hong Liu; Yang Yu; Jun Zhang; Yanfei Li; Guanghua Luo; Xiaoying Zhang; Ning Xu
Journal:  Mol Med Rep       Date:  2020-08-11       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.